Loading...
•
Mar 31, 2024
Ekso Bionics Q1 2024 Earnings Report
Ekso Bionics reported first quarter 2024 financial results, showing a decrease in revenue but an increase in gross margin.
Key Takeaways
Ekso Bionics reported a revenue of $3.8 million for Q1 2024, compared to $4.1 million in the same period last year. The company's gross margin increased to 52%, and the net loss decreased to $3.4 million, or $0.20 per share.
Revenue was $3.8 million, down from $4.1 million in the same quarter of the previous year.
Gross profit reached $2.0 million, with a gross margin of approximately 52%.
Net loss applicable to common stockholders was $3.4 million, or $0.20 per share.
Cash and restricted cash stood at $8.8 million as of March 31, 2024.
Forward Guidance
Ekso Bionics is focused on developing the market for Indego Personal and strengthening relationships with network operators for Enterprise devices.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...